首页> 美国卫生研究院文献>other >Serotonergic Activation of Locomotor Behavior and Posture in One-day Old Rats
【2h】

Serotonergic Activation of Locomotor Behavior and Posture in One-day Old Rats

机译:一天龄大大鼠运动行为和姿势的血清素能激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The purpose of this study was to determine what dose of quipazine, a serotonergic agonist, facilitates air-stepping and induces postural control and patterns of locomotion in newborn rats. Subjects in both experiments were 1-day-old rat pups. In Experiment 1, pups were restrained and tested for air-stepping in a 35-min test session. Immediately following a 5-min baseline, pups were treated with quipazine (1.0, 3.0, or 10.0 mg/kg) or saline (vehicle control), administered intraperitoneally in a 50 microliter injection. Bilateral alternating stepping occurred most frequently following treatment with 10.0 mg/kg quipazine, however the percentage of alternating steps, interlimb phase, and step period were very similar between the 3.0 and 10.0 mg/kg doses. For interlimb phase, the forelimbs and hindlimbs maintained a near perfect anti-phase pattern of coordination, with step period averaging about 1 second. In Experiment 2, pups were treated with 3.0 or 10.0 mg/kg quipazine or saline, and then were placed on a surface (open field, unrestrained). Both doses of quipazine resulted in developmentally advanced postural control and locomotor patterns, including head elevation, postural stances, pivoting, crawling, and a few instances of quadrupedal walking. The 3.0 mg/kg dose of quipazine was the most effective at evoking sustained locomotion. Between the 2 experiments, behavior exhibited by the rat pup varied based on testing environment, emphasizing the role that environment and sensory cues exert over motor behavior. Overall, quipazine administered at a dose of 3.0 mg/kg was highly effective at promoting alternating limb coordination and inducing locomotor activity in both testing environments.
机译:这项研究的目的是确定什么剂量的奎巴嗪(一种血清素能激动剂)促进空气步进并诱导新生大鼠的姿势控制和运动方式。两个实验中的受试者均为1天大的幼仔。在实验1中,在35分钟的测试过程中对幼犬进行约束并进行空气踩踏测试。基线5分钟后,立即以50微升注射液腹腔注射quipazine(1.0、3.0或10.0 mg / kg)或生理盐水(媒介物对照)处理幼犬。在用10.0 mg / kg喹嗪治疗后,双边交替踩踏最常发生,但是在3.0和10.0 mg / kg剂量之间,交替踩踏的百分比,中间相和步长周期非常相似。对于中间相,前肢和后肢保持近乎完美的反相配位模式,步长平均约为1秒。在实验2中,将幼犬用3.0或10.0 mg / kg的喹嗪或盐水处理,然后将其放在表面上(开放视野,不受约束)。两种剂量的奎巴嗪均导致发展中的高级姿势控制和运动模式,包括头部抬高,姿势姿势,枢转,爬行和一些四足行走的情况。 3.0 mg / kg剂量的quipazine在引起持续运动方面最有效。在这两个实验之间,大鼠幼崽表现出的行为根据测试环境而有所不同,强调了环境和感官提示在运动行为中发挥的作用。总体而言,在两种测试环境中,以3.0 mg / kg的剂量服用喹嗪非常有效地促进交替的肢体协调并诱导运动能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号